Smart algorithm finds possible future treatment for childhood cancer

Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialised nerve cells in the sympathetic nervous system, may be life-threatening. In the long term the discovery may result in a new form of treatment for children in whom the disease is severe or at an advanced stage

Photo
The image shows a zebrafish embryo with cancer cells (green) in its nervous system. The researchers used this type of animal model to evaluate new treatments.
Source: Elin Almstedt, Uppsala University

The new treatment is based on activating a receptor protein, CNR2 (cannabinoid receptor 2), in the nervous system. A highly unusual method enabled this particular protein to be applied therapeutically. Instead of using traditional methods of drug development, this research group has developed a new computer algorithm capable of combining massive quantities of genetic and pharmacological data (‘big data’) from European and American hospitals and universities. The algorithm then suggested new treatments that could influence the basic mechanisms of the disease. “We were astonished when the algorithm came up with completely new ideas for treatment, such as CNR2, that no one has ever discussed in this context. So we decided to investigate this further in the lab,” says Sven Nelander, senior lecturer at Uppsala University’s Department of Immunology, Genetics and Pathology, who is in charge of the study.

The new treatments were investigated using cell samples from patients and in animal models, where they proved efficacious. The cancer cells’ survival rate declined, for example, and tumour growth in zebrafish (Danio rerio) decreased, following treatment with a substance that stimulates CNR2.

The researchers have also developed the computer algorithm to enable it to be applied to other forms of cancer. “Smart algorithms will be increasingly important in cancer research in the years ahead, since they can help us scientists to find unexpected angles. We’ve already started a major project here in Uppsala, in which several types of cancer in children and adults will be investigated this way. Our hope is that this can result in more unexpected treatment options,” Nelander says.

Subscribe to our newsletter

Related articles

Deep learning identifies molecular patterns of cancer

Deep learning identifies molecular patterns of cancer

An AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.

Digital attack on cancer

Digital attack on cancer

Several research groups at the Berlin Institute of Health (BIH) are working on digitally combating cancer, comparing experiences with different diagnostic and treatment methods.

Big datasets help identify causes for pediatric diseases

Big datasets help identify causes for pediatric diseases

Researchers use the analogy of raindrops on the sidewalk to explain their new method to identify genetic variations that cause severe pediatric diseases.

Using big data to predict immunotherapy responses

Using big data to predict immunotherapy responses

In the age of big data, cancer researchers are discovering new ways to monitor the effectiveness of immunotherapy treatments.

AI tracks down acute myeloid leukemia

AI tracks down acute myeloid leukemia

Artificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reliability.

AI identifies features associated with cancer recurrence

AI identifies features associated with cancer recurrence

An AI has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.

AI detects even the smallest metastases

AI detects even the smallest metastases

Researchers have developed a new algorithm that enables automated detection of metastases at the level of single disseminated cancer cells in whole mice.

ConvPath software uses AI to identify cancer cells

ConvPath software uses AI to identify cancer cells

A software tool uses artificial intelligence to recognize cancer cells from digital pathology images — giving clinicians a powerful way of predicting patient outcomes.

Sensor chip detects cancer biomarker in urine

Sensor chip detects cancer biomarker in urine

Researchers have used a chip-based sensor with an integrated laser to detect very low levels of a cancer protein biomarker in a urine sample.

Popular articles